Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185(HER-2) in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections

British Journal of Cancer

Volumn 74, Issue 1, 1996, Pages 86-91

  Pfeiffer, P ^a   Clausen, P P ^a   Andersen, K ^a   Rose, C ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidermal growth factor receptor; Non small cell lung cancer; p185(Her 2)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; ONCOPROTEIN; POLYCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0030054716     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.320     Document Type: Article

References (41)

1. ALTMAN DG, LAUSEN B, SAUERBREI W AND SCHUMACHER M. (1994). Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J. Natl Cancer Inst., 86, 829-835.
2. BERGER MS, GULLICK WJ, GREENFIELD C, EVANS S, ADDIS BJ AND WATERFIELD MD. (1987). Epidermal growth factor receptors in lung tumours. J. Pathol., 152, 297-307.
3. BOLUFER P, LLUCH A, MOLINA R, ALBEROLA V, VAZQUEZ C, PADILLA J, GARCIA CONDE J, LLOPIS F AND GUILLEM V. (1993). Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM. Clin. Chim. Acta, 215, 51-61.
4. BONGIORNO PF, WHYTE RI, LESSER EJ, MOORE JH, ORRINGER MB AND BEER DG. (1994). Alterations of K-ras, p53, and erbB-2/ neu in human lung adenocarcinomas. J. Thorac. Cardiovasc. Surg., 107, 590-595.
5. CERNY T, BARNES DM, HASLETON P, BARBER PV, HEALY K, GULLICK WJ AND THATCHER N. (1986). Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br. J. Cancer, 54, 265-269.
6. DAZZI H, HASLETON PS, THATCHER N, BARNES DM, WILKES S, SWINDELL R AND LAWSON RA. (1989). Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. Br. J. Cancer, 59, 746-749.
7. DI CARLO A, MARIANO A, MACCHIA PE, CECERE C, FERRANTE G AND MACCHIA V. (1993). Epidermal growth factor receptor and lipid membrane components in human lung cancers. J. Endocrinol. Invest., 16, 99-107.
8. DITTADI R, GION M, PAGAN V, BRAZZALE A, DEL MASCHIO O, BARGOSSI A, BUSETTO A AND BRUSCAGNIN G. (1991). Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Br. J. Cancer, 64, 741-744.
9. GAZDAR AF. (1994). The molecular and cellular basis of human lung cancer. Anticancer Res., 14, 261-267.
10. GORGOULIS V, ANINOS D, MIKOU P, KANAVAROS P, KARAMERIS A, JOAR-DANOGLOU J, RASIDAKIS A, VESLEMES M, OZANNE B AND SPANDIDOS DA. (1992). Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas. Anticancer Res., 12, 1183-1187.
11. GULLICK WJ. (1991). Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull., 47, 87-98.
12. HENDLER FJ AND OZANNE B. (1984). Human squamous cell lung cancers express increased epidermal growth factor receptors. J. Clin. Invest., 74, 647-651.
13. HOLMES EC. (1993). Postoperative chemotherapy for non-small-cell lung cancer. Chest, 103, 30S-34S.
14. KASEDA S, UEDA M, OZAWA S, ISHIHARA T, ABE O AND SHIMIZU N. (1989). Expression of epidermal growth factor receptors in four histologic cell types of lung cancer. J. Surg. Oncol., 42, 16-20.
15. KERN JA, SCHWARTZ DA, NORDBERG JE, WEINER DB, GREENE MI, TORNEY L AND ROBINSON RA. (1990). p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50, 5184-5187.
16. KERN JA, SLEBOS RJ, TOP B, RODENHUIS S, LAGER D, ROBINSON RA, WEINER DB AND SCHWARTZ DA. (1994). C-erbB-2 expression and codon 12K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93, 516-520.
17. KNOOP AS, LAENKHOLM A, MIRZA MR, HANSEN S, THORPE SM AND ROSE C. (1994). Prognostic and predictive factors in early breast cancer. Proc. ESMO, 19 (II), 9-18.
18. KOKAI Y, MYERS JN, WADA T, BROWN VI, LEVEA CM, DAVIS JG, DOBASHI K AND GREENE MI. (1989). Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
19. MOUNTAIN CF. (1994). Staging and surgical treatment of lung cancer. Adv. Oncol., 9, 10-14.
20. PRIGENT SA AND LEMOINE NR. (1992). The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res., 4, 1-24.
21. RAVDIN PM AND CHAMNESS GC. (1995). The c-erbB-2 protooncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene, 159, 19-27.
22. RICHARDSON GE AND JOHNSON BE. (1993). The biology of lung cancer. Semin. Oncol., 20, 105-127.
23. ROSELL R, GOMEZ CODINA J, CAMPS C, MAESTRE J, PADILLE J, CANTO A, MATE JL, LI S, ROIG J, OLAZABAL A, CANELA M, ARIZA A, SKACEL Z, MORERA-PRAT J AND ABAD A. (1994). A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer [see comments]. N. Engl. J. Med., 330 153-158.
24. ROTH JA, FOSSELLA F, KOMAKI R, RYAN MB, PUTNAM JB JR, LEE JS, DHINGRA H, DE CARO L, CHASEN M, MCGAVRAN M, ATKINSON EN AND HONG WK. (1994). A randomized trial comparing perioperative chemotherapy and surgery with surgery-alone in resectable stage IIIA non-small-cell lung cancer. J. Natl Cancer Inst., 86, 673-680.
25. RUSCH V, BASELGA J, CORDON-CARDO C, ORAZEM J, ZAMAN M, HODA S, MCINTOSH J, KURIE J AND DMITROVSKY E. (1993). Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res., 53, 2379-2385.
26. SCAGLIOTTI GV, LEONARDO E, CAPPIA S, MASIERO P, MICELA M, GUBETTA L AND POZZI E. (1993). Epidermal growth factor receptor and neu-oncogene expression in lung cancer. Proc. ASCO, 12, 328.
27. SHI D, HE G, CAO S, PAN W, ZHANG HZ, YU D AND HUNG MC (1992). Overexpression of the c-erbB-2/neu-encoded p 185 protein in primary lung cancer. Mol. Carcinogen., 5, 213-218.
28. SIMON R AND ALTMAN DG. (1994). Statistical aspects of prognostic factor studies in oncology [editorial]. Br. J. Cancer, 69, 979-985.
29. SOBOL RE, ASTARITA RW, HOFEDITZ C, MASUI H, FAIRSHTER R, ROYSTON I AND MENDELSOHN J. (1987). Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J. Natl Cancer Inst., 79, 403-405.
30. SOUQUET PJ, CHAUVIN F, BOISSEL JP, CELLERINO R, CORMIER Y, GANZ PA, KAASA S, PATER JL, QUOIX E, RAPP E, TUMARELLO D, WILLIAMS J, WOODS BL AND BERNARD JP (1993). Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet, 342, 19-21.
31. TATEISHI M, ISHIDA T, MITSUDOMI T, KANEKO S AND SUGIMACHI K. (1990). Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res., 50, 7077-7080.
32. TATEISHI M, ISHIDA T, MITSUDOMI T, KANEKO S AND SUGIMACHI K. (1991). Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur. J. Cancer, 27, 1372-1375.
33. VEALE D, ASHCROFT T, MARSH C, GIBSON GJ AND HARRIS AL. (1987). Epidermal growth factor receptors in non-small cell lung cancer. Br. J. Cancer, 55, 513-516.
34. VEALE D, KERR N, GIBSON GJ AND HARRIS AL. (1989). Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res., 49, 1313-1317.
35. VEALE D, KERR N, GIBSON GJ, KELLY PJ AND HARRIS AL. (1993). The relationship of quantitative epidermal growth factor receptor in non-small cell lung cancer to long term survival. Br. J. Cancer, 68, 162-165.
36. VOLM M, EFFERTH T AND MATTERN J. (1992). Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res., 12, 11-20.
37. VOLM M AND MATTERN J. (1993). Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Anticancer Res., 13, 2021-2025.
38. VOLM M, DRINGS P AND WODRICH W. (1993). Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J. Cancer Res. Clin. Oncol., 119, 507-510.
39. WATERFIELD MD, MAYES EL, STROOBANT P, BENNET PL, YOUNG S, GOODFELLOW PN, BANTING GS AND OZANNE B. (1982). A monoclonal antibody to the human epidermal growth factor receptor. J. Cell. Biochem., 20, 149-161.
40. WEINER DB, NORDBERG J, ROBINSON R, NOWELL PC, GAZDAR A, GREENE MI, WILLIAMS WV, COHEN JA AND KERN JA. (1990). Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res., 50, 421-425.
41. WORLD HEALTH ORGANIZATION. (1981). Histological typing of lung tumours. Tumori, 67, 253-272.